Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Vij

Showing results (271-280 of 283) with videos related to

Pageof 29
Sort By:
The New England Journal of Medicine|August 22, 2019
Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple MyelomaAjai Chari, Dan T Vogl, Maria Gavriatopoulou, et al.
Nature Genetics|June 9, 2025
Author Correction: Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypesSheri Skerget, Daniel Penaherrera, Ajai Chari, et al.
Nature Genetics|August 19, 2024
Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypesSheri Skerget, Daniel Penaherrera, Ajai Chari, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2020
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic SyndromesAziz Nazha, Zhen-Huan Hu, Tao Wang, et al.
Mayo Clinic Proceedings|February 2, 2010
Conflicts of interest, authorship, and disclosures in industry-related scientific publicationsRafael Fonseca, Paul Richardson, Sergio Giralt, et al.
Nature Cancer|January 9, 2026
A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myelomaWilliam C Pilcher, Lijun Yao, Edgar Gonzalez-Kozlova, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myelomaWilliam C Pilcher, Lijun Yao, Edgar Gonzalez-Kozlova, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 16, 2019
Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell TransplantationAyman Saad, Lawrence Lamb, Tao Wang, et al.
Blood Advances|January 15, 2020
A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestryZhaohui Du, Niels Weinhold, Gregory Chi Song, et al.
Haematologica|September 28, 2019
Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant ResearchAleksandr Lazaryan, Michelle Dolan, Mei-Jie Zhang, et al.
Pageof 29

Showing results (271-280 of 283) with videos related to

Sort By:
Pageof 29
The New England Journal of Medicine|August 22, 2019
Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple MyelomaAjai Chari, Dan T Vogl, Maria Gavriatopoulou, et al.
Nature Genetics|June 9, 2025
Author Correction: Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypesSheri Skerget, Daniel Penaherrera, Ajai Chari, et al.
Nature Genetics|August 19, 2024
Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypesSheri Skerget, Daniel Penaherrera, Ajai Chari, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2020
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic SyndromesAziz Nazha, Zhen-Huan Hu, Tao Wang, et al.
Mayo Clinic Proceedings|February 2, 2010
Conflicts of interest, authorship, and disclosures in industry-related scientific publicationsRafael Fonseca, Paul Richardson, Sergio Giralt, et al.
Nature Cancer|January 9, 2026
A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myelomaWilliam C Pilcher, Lijun Yao, Edgar Gonzalez-Kozlova, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myelomaWilliam C Pilcher, Lijun Yao, Edgar Gonzalez-Kozlova, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 16, 2019
Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell TransplantationAyman Saad, Lawrence Lamb, Tao Wang, et al.
Blood Advances|January 15, 2020
A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestryZhaohui Du, Niels Weinhold, Gregory Chi Song, et al.
Haematologica|September 28, 2019
Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant ResearchAleksandr Lazaryan, Michelle Dolan, Mei-Jie Zhang, et al.
Pageof 29